{
    "eid": "2-s2.0-85088158244",
    "title": "Newly discovered abnormal glucose tolerance in patients with acute myocardial infarction and cardiovascular outcomes: A meta-analysis",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Internal Medicine",
            "@code": "2724",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Endocrinology, Diabetes and Metabolism",
            "@code": "2712",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Advanced and Specialized Nursing",
            "@code": "2902",
            "@abbrev": "NURS"
        }
    ],
    "keywords": [],
    "authors": [
        "Nitchakarn Laichuthai",
        "Muhammad Abdul-Ghani",
        "Mikhail Kosiborod",
        "Wasita Warachit Parksook",
        "Stephen J. Kerr",
        "Ralph A. Defronzo"
    ],
    "citedby-count": 10,
    "ref-count": 60,
    "ref-list": [
        "Banting Lecture. From the tri-umvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus",
        "Intensive blood-glucose control with sulphonyl-ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet 1999;354:602]",
        "Diabetes and cardiovascular disease. The Framingham study",
        "New risk factors for atherosclerosis and patient risk assessment",
        "IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040",
        "Heart disease and stroke statistics-2019 update: a report from the American Heart Association [published correction appears in Circulation 2020;141:e33]",
        "Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis",
        "The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart",
        "Effect of a multifactorial intervention on mortality in type 2diabetes",
        "Diagnosis and classification of diabetes mellitus [published correction appears in Diabetes Care 2010;33:e57]",
        "Meta-analysis of prevalence",
        "Introduc-tion,comparison,andvalidationofMeta-Essentials: a free and simple tool for meta-analysis",
        "Sensitivity analysis in observational research: introducing the E-value",
        "Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort",
        "Newly detected abnormal glucose regulation and long-term prognosis after acute myo-cardial infarction: comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c",
        "A 3-year follow-up of the Silent Diabetes Study",
        "The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively",
        "Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myo-cardial infarction: a scientific study",
        "Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction",
        "Long-termclinicaloutcome in patients with acute coronary syndrome and dysgly-caemia",
        "Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities",
        "Impaired glucose tolerance or newly diagnosed diabetes mellitus diagnosed during admission ad-versely affects prognosis after myocardial infarction: anobservationalstudy",
        "Adjustment of the GRACE score by 2-hour post-load glucose improves prediction of long-term major adverse cardiac events in acute coronary syndrome in patients without known diabetes",
        "Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart",
        "Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population",
        "Prevalence and clinical outcomes of undiagnosed diabetesmellitusandprediabetesamongpatientswith high-risk non-ST-segment elevation acute coronary syndrome",
        "Utility of glycated hemoglobin for assessment of glucose metabolism in patients with ST-segment elevation myocardial infarction",
        "Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary interven-tion",
        "Prospective study of the impact of diabetes mellitus newly diagnosedbyglycatedhemoglobinonoutcomesin patients undergoing percutaneous coronary in-tervention",
        "Impactofinitialglycosylatedhemoglobinlevelon cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary in-tervention",
        "Clinical impact of borderline and undiagnosed diabetes mellitus in patients with coronary artery disease",
        "Impaired fasting glucose in combination with silent myocardial ischaemia is associated with poor prognosis in healthy indi-viduals",
        "Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities)",
        "Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock forcoronary heartdisease starttickingbefore the onset of clinical diabetes?",
        "Association of glycaemia with macrovascular and mi-crovascular complications of type 2 diabetes (UKPDS 35): prospective observational study",
        "Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009",
        "Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria",
        "Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II study",
        "Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study",
        "Acarbose treatment and the risk of cardiovascular disease and hypertension in patients withimpairedglucosetolerance:theSTOP-NIDDM trial",
        "Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial",
        "Cardiovascular effects of intensive lifestyle intervention in type 2 di-abetes",
        "Pioglitazone after ischemic stroke or transient ischemic attack",
        "Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors",
        "Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis",
        "Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-anal-ysis",
        "Liraglutide and cardiovascular outcomes in type 2 diabetes",
        "Semaglutide and cardiovascular outcomes in patients with type 2 diabetes",
        "Harmony Outcomes committees and in-vestigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial",
        "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes",
        "Canagli-flozin and cardiovascular and renal events in type 2 diabetes",
        "Dapagli-flozin and cardiovascular outcomes in type 2 diabetes",
        "Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis",
        "Class effect for sodium glucose-cotransporter-2 inhibitors in cardiovascular outcomes: implications for the cardiovascular disease specialist",
        "SGLT2 inhibitors and cardiovascular risk: lessons learned from the EMPA-REG OUTCOME study",
        "Canagliflozin and renal outcomes in type 2 diabetes and nephropathy",
        "Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocar-dial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study",
        "The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy",
        "Pharma-cologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2020"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60104730",
            "affilname": "George Institute for Global Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60104730",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Kansas City",
            "@id": "60030631",
            "affilname": "Mid America Heart Institute - Kansas City",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030631",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Kensington",
            "@id": "60026655",
            "affilname": "The Kirby Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "San Antonio",
            "@id": "60018573",
            "affilname": "University of Texas Health Science Center at San Antonio",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Lorrie Albarado",
        "Boehringer Ingelheim",
        "AstraZeneca",
        "Merck",
        "Janssen"
    ]
}